Healthpeak Properties, Inc. (DOC)
NYSE: DOC · Real-Time Price · USD
17.37
-0.15 (-0.86%)
May 30, 2025, 2:00 PM - Market open
Healthpeak Properties Stock Forecast
Stock Price Forecast
According to 10 professional analysts, the 12-month price target for Healthpeak Properties stock ranges from a low of $21 to a high of $28. The average analyst price target of $23.3 forecasts a 34.14% increase in the stock price over the next year.
Price Target: $23.30 (+34.14%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Healthpeak Properties stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Hold | 5 | 5 | 3 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 11 | 11 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Scotiabank | Scotiabank | Buy Maintains $23 → $21 | Buy | Maintains | $23 → $21 | +20.90% | May 12, 2025 |
| Argus Research | Argus Research | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +43.93% | Apr 29, 2025 |
| Baird | Baird | Buy Maintains $24 → $22 | Buy | Maintains | $24 → $22 | +26.66% | Apr 29, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $23 → $21 | Buy | Maintains | $23 → $21 | +20.90% | Apr 28, 2025 |
| Wedbush | Wedbush | Buy Maintains $24 → $22 | Buy | Maintains | $24 → $22 | +26.66% | Apr 28, 2025 |
Financial Forecast
Revenue This Year
2.81B
from 2.70B
Increased by 4.06%
Revenue Next Year
2.92B
from 2.81B
Increased by 4.06%
EPS This Year
0.24
from 0.36
Decreased by -33.97%
EPS Next Year
0.29
from 0.24
Increased by 23.70%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 3.0B | 3.2B | 3.3B | |
| Avg | 2.8B | 2.9B | 3.0B | |
| Low | 2.6B | 2.7B | 2.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 12.0% | 14.2% | 11.8% | |
| Avg | 4.1% | 4.1% | 2.4% | |
| Low | -2.4% | -4.7% | -4.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.28 | 0.39 | 0.40 | ||
| Avg | 0.24 | 0.29 | 0.28 | ||
| Low | 0.19 | 0.20 | 0.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -20.9% | 64.1% | 36.2% | ||
| Avg | -34.0% | 23.7% | -4.3% | ||
| Low | -48.1% | -17.2% | -33.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.